Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Investment Tools And Research To Help Make You A More Confident And Profitable Trader. FREE 30 Day Trial
Stocks | Futures | Watchlist | More
or

Celldex Therapeutics (CLDX)

Celldex Therapeutics (CLDX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 2,484,186
  • Shares Outstanding, K 65,911
  • Annual Sales, $ 6,880 K
  • Annual Income, $ -141,430 K
  • 60-Month Beta 1.47
  • Price/Sales 345.79
  • Price/Cash Flow N/A
  • Price/Book 2.41
Trade CLDX with:

Options Overview Details

View History
  • Implied Volatility 55.81% ( -0.02%)
  • Historical Volatility 40.96%
  • IV Percentile 47%
  • IV Rank 9.40%
  • IV High 196.09% on 11/02/23
  • IV Low 41.26% on 06/24/24
  • Put/Call Vol Ratio 0.22
  • Today's Volume 11
  • Volume Avg (30-Day) 45
  • Put/Call OI Ratio 1.96
  • Today's Open Interest 7,289
  • Open Int (30-Day) 7,944

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 10 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/24
See More
  • Average Estimate -0.59
  • Number of Estimates 6
  • High Estimate -0.51
  • Low Estimate -0.67
  • Prior Year -0.65
  • Growth Rate Est. (year over year) +9.23%

Price Performance

See More
Period Period Low Period High Performance
1-Month
32.25 +14.76%
on 06/04/24
38.05 -2.73%
on 06/28/24
+1.63 (+4.61%)
since 05/28/24
3-Month
32.25 +14.76%
on 06/04/24
43.35 -14.63%
on 05/07/24
-4.96 (-11.82%)
since 03/28/24
52-Week
22.11 +67.39%
on 10/30/23
53.18 -30.41%
on 03/04/24
+1.96 (+5.59%)
since 06/28/23

Most Recent Stories

More News
Stocks Post Modest Gains on Mixed US Economic Reports

The S&P 500 Index ($SPX ) (SPY ) today is up +0.17%, the Dow Jones Industrials Index ($DOWI ) (DIA ) is up +0.24%, and the Nasdaq 100 Index ($IUXX ) (QQQ ) is up +0.03%. Stock indexes today are slightly...

$SPX : 5,460.48 (-0.41%)
SPY : 544.22 (-0.39%)
$DOWI : 39,118.86 (-0.12%)
DIA : 391.13 (-0.11%)
$IUXX : 19,682.87 (-0.54%)
QQQ : 479.11 (-0.52%)
ZNU24 : 109-315s (-0.24%)
MU : 131.53 (-0.53%)
QCOM : 199.18 (+2.07%)
LZB : 37.28 (+2.56%)
CLDX : 37.01 (-1.80%)
KR : 49.93 (+1.13%)
Celldex: Q1 Earnings Snapshot

Celldex: Q1 Earnings Snapshot

CLDX : 37.01 (-1.80%)
Celldex: Q4 Earnings Snapshot

Celldex: Q4 Earnings Snapshot

CLDX : 37.01 (-1.80%)
Why Celldex Therapeutics Blasted 13% Higher on Monday

The biotech's CSU treatment advanced in the laboratory.

CLDX : 37.01 (-1.80%)
Freshpet, Celldex Therapeutics rise; TreeHouse Foods, Dish Network fall, Monday, 11/6/2023

Stocks that traded heavily or had substantial price changes on Monday: Freshpet, Celldex Therapeutics rise; TreeHouse Foods, Dish Network fall

CLDX : 37.01 (-1.80%)
THS : 36.64 (+0.55%)
HGV : 40.43 (+2.61%)
DISH : 5.77 (+1.94%)
FRPT : 129.39 (+0.11%)
Celldex: Q3 Earnings Snapshot

Celldex: Q3 Earnings Snapshot

CLDX : 37.01 (-1.80%)
Celldex: Q2 Earnings Snapshot

Celldex: Q2 Earnings Snapshot

CLDX : 37.01 (-1.80%)
Celldex: Q1 Earnings Snapshot

Celldex: Q1 Earnings Snapshot

CLDX : 37.01 (-1.80%)
Celldex: Q4 Earnings Snapshot

Celldex: Q4 Earnings Snapshot

CLDX : 37.01 (-1.80%)
Celldex: Q3 Earnings Snapshot

Celldex: Q3 Earnings Snapshot

CLDX : 37.01 (-1.80%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 40% Sell with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

CELLDEX THERAPEUTICS is an integrated biopharmaceutical company that applies its comprehensive Precision Targeted Immunotherapy Platform to generate a pipeline of candidates to treat cancer and other difficult-to-treat diseases. Celldex's immunotherapy platform includes a complementary portfolio of monoclonal...

See More

Key Turning Points

3rd Resistance Point 39.77
2nd Resistance Point 38.91
1st Resistance Point 37.96
Last Price 37.01
1st Support Level 36.15
2nd Support Level 35.29
3rd Support Level 34.34

See More

52-Week High 53.18
Fibonacci 61.8% 41.31
Fibonacci 50% 37.65
Last Price 37.01
Fibonacci 38.2% 33.98
52-Week Low 22.11

See More

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar